Yong Huo, MD; Jianping Li, MD, PhD; Xianhui Qin, PhD; et al.
This randomized, double-blind clinical trial found that among adults with hypertension in China without a history of stroke or myocardial infarction, the combined use of enalapril and folic acid, compared with enalapril alone, significantly reduced the risk of first stroke.